What is the situation in Paris and Ile-de-France as of Monday October 18, 2021 like? Discover the latest data as for the Covid-19 epidemic and the latest news applying to the Parisian area under the main news. In Île-de-France, and especially in Paris, indicators of the evolution of the epidemic are deteriorating and the 4th wave is worrying.
Latest and main news about Covid-19 in Paris and Île-de-France:
Coronavirus in Paris and Ile-de-France: +15 Covid deaths in 24h, 241 patients in ICU
Let us take a stock on the situation in Paris and Île-de-France. Discover the report about the Parisian region per department. This Monday 18 October 2021, +15 more deaths in 24h have been reported, and 241 patients are in ICU. [Read more]
Paris and Île-de-France incidence rate as of Monday 18 October 2021
In France, the second epidemic wave keeps on spreading in many areas. Curfew has been brought forward to 6 p.m. since January 16, 2021 instead of 8 p.m. Health authorities have set the incidence rate per department as a determining criterion to know if measures should be made harder or easier. To make Île-de-France inhabitants’ life easier, here is the incidence rate map by departments in Paris and Île-de-France as of Monday 18 October 2021, based on data shared by CovidTracker and Data.gouv. [Read more]
Coronavirus Paris – Île-de-France: how many people are vaccinated in the area as of Monday 18 October 2021?
In Île-de-France, the coronavirus epidemic is heading towards a third wave as the vaccine campaign still goes on. As of Coronavirus Paris – Île-de-France: how many people are vaccinated in the area as of Monday 18 October 2021?, how many French have been vaccinated in the Paris area so far? Keep reading to find out more. [Read more]
Covid – AstraZeneca: conclusive results for the rolling-reviewed antibody therapy
This Monday October 11, 2021, AstraZeneca laboratory issued a release stating phase 3 of the antibody-based Covid therapy clinical trial is successful. This therapy is said to cut risks of developing severe disease by 67%. Here is more on the matter! [Read more]
Covid: Merck seeks FDA emergency use authorization for Monulpiravir
Good news amid the fight against Covid! Drugmakers Merck and Ridgeback Bio have announced in April their molnupiravir therapy against the virus led to promising results. This Monday October 11? 2021, the company has announced they are seeking FDA emergency use authorization for this oral drug. [Read more]
Health Pass: the Scientific Committee's two recommendations to get out of the woods
As France is starting another months of restrictions because of the Covid-19 epidemic, the issue about keep the health pass in the long or medium run is on the executive's agenda. This Thursday October 7, 2021, the Scientific Committee addressed two different scenarios for a "quick and even immediate exit" or a "delayed exit" between November 15 and the end of the year. Keep reading to find out more. [Read more]
Covid: reinfection risk higher when the Delta variant is the dominant strain
The latest report of the UK Office for National Statistics says the Covid reinfection risk is almost two times higher in the event the Delta variant is the dominant strain. [Read more]
Covid: no more free tests from this October 15, how much do they cost? To whom do they apply?
PCR and antigenic tests – necessary for unvaccinated to get a valid health pass – will become charged starting from October 15, excluding medical prescriptions. How much will they cost, then and to whom do they apply? Keep reading to find out more. [Read more]
Covid: What if France could prevent the fifth wave?
Will France be hit by a fifth covid wave? As back in early September the Institut Pasteur explained in a study it would be “hard to prevent”, this early October 2021, epidemiologists sound more optimistic. Keep reading to find out more! [Read more]
Covid: the pandemic is still not under control, WHO warns
As the Covid-19 pandemic is slowing down in many countries thanks to vaccination, this Tuesday October 5, the WHO intended to remind the novel coronavirus was still not under control. [Read more]
Covid: Pfizer vaccine effective at least 6 months against severe disease
A study published today in The Lancet shows the Pfizer vaccine is effective at least 6 months against severe Covid. [Read more]
Covid vaccination: 75.2% of the French population given the first dose
While the fourth Covid-19 wave keeps on spreading across the world, especially in Europe, the vaccination campaign has been escalating for many months in France. As of Tuesday October 5, 2021, the first dose of vaccine has been given to 75.2% of the French population, and 72.8% of the population is fully vaccinated. [Read more]
Covid: The hospitalization toll slightly increases in France
After decreasing for several weeks in a row, the hospitalization toll is slightly increasing again in France. As of Sunday October 17, 2021, 6,448 hospitalized Covid-19 sick have been reported in France, against 6,437 the day before and 6,737 a week ago. [Read more]
Covid: 74% of employees wish to dith facemask-wearing within companies
As facemask-wearing is to be lifted for people in places subject to the health pass, Labor Minister reminds employees from these places are not involved in this softening. "Facemask-wearing remain the rule in companies", the Minister insists on. A source of frustration for employees, as 74% of them are for the end of facemask-wearing within companies, according to an Ipsos-Sopra Steria survey released this October 4, 2021. [Read more]
Paris - Ile de France
0800 130 000